Literature DB >> 3794395

Septicemic plague in New Mexico.

H F Hull, J M Montes, J M Mann.   

Abstract

Eighteen of the 71 cases of plague reported in New Mexico from 1980 to 1984 were septicemic. We reviewed these cases to better describe the clinical presentation of this disorder and to identify risk factors for developing septicemic plague. The symptoms (fever, chills, malaise, headache, and gastrointestinal symptoms) and signs (tachycardia, tachypnea, and hypotension) of septicemic plague are similar to those of other forms of gram-negative septicemia. Abdominal pain was reported in nearly half of the cases, and differential white blood cell counts revealed a marked shift to the left. The risk of developing septicemic plague was higher for persons greater than 40 years of age. Because of empirical antibiotic treatment of older persons, deaths from septicemic plague occurred primarily among persons less than 30 years old. Deaths from septicemic plague could be reduced by aggressive antibiotic therapy for patients with a clinical presentation suggesting gram-negative septicemia, especially patients less than 30 years old.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3794395     DOI: 10.1093/infdis/155.1.113

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Pulmonary Manifestations of Bioterrorism.

Authors:  Renuka Heddurshetti; Wadchara Pumpradit; Larry I. Lutwick
Journal:  Curr Infect Dis Rep       Date:  2001-06       Impact factor: 3.725

2.  Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague.

Authors:  Florent Sebbane; Clayton O Jarrett; Donald Gardner; Daniel Long; B Joseph Hinnebusch
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

3.  Plague--clinical features and management.

Authors:  S K Kabra; Y Jain; V Seth
Journal:  Indian J Pediatr       Date:  1994 Nov-Dec       Impact factor: 1.967

4.  Plague in India.

Authors:  D T Dennis
Journal:  BMJ       Date:  1994-10-08

5.  In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.

Authors:  Jered M Wendte; Duraisamy Ponnusamy; Deanna Reiber; Jeffrey L Blair; Kenneth D Clinkenbeard
Journal:  Antimicrob Agents Chemother       Date:  2011-05-31       Impact factor: 5.191

6.  Antibiotic treatment of experimental pneumonic plague in mice.

Authors:  W R Byrne; S L Welkos; M L Pitt; K J Davis; R P Brueckner; J W Ezzell; G O Nelson; J R Vaccaro; L C Battersby; A M Friedlander
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

Review 7.  Yersinia pestis--etiologic agent of plague.

Authors:  R D Perry; J D Fetherston
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

8.  Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection.

Authors:  S P Bonacorsi; M R Scavizzi; A Guiyoule; J H Amouroux; E Carniel
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

9.  Plague meningitis--a retrospective analysis of cases reported in the United States, 1970-1979.

Authors:  T M Becker; J D Poland; T J Quan; M E White; J M Mann; A M Barnes
Journal:  West J Med       Date:  1987-11

Review 10.  Clinical implications of positive blood cultures.

Authors:  C S Bryan
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.